Clinical Trial Update: 2-week dc of MTX and Influenza Vaccination in RA [NA]

View source ↗

Summary

A clinical trial evaluating a 2-week discontinuation of methotrexate around influenza vaccination in rheumatoid arthritis patients; the trial status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Rheumatoid Arthritis, Influenza | NA | Status: UNKNOWN